For OSCC patients, in whom the lymph nodes or recurrence tumors were unavailable for EGFR gene copy number analysis, studies of the primary tumor could provide part of the EGFR clonal information to predict metastatic or recurrent lesions. Here, EGFR is linked to neoplasm.